Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice
1Department of Neurology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Journal of Neurology, Neurosurgery, and Psychiatry
|November 12, 2014
Abstract
No abstract available in PubMed .
More Related Videos
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
3.1K
05:45Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
Published on: April 5, 2019
24.4K
